Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunocompromised”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07295535
What this trial is testing

Analysis of the Specificity and Persistence of Nasal Immune Responses to Respiratory Viral Antigens in Immunocompromised and Healthy Cohorts

Who this might be right for
Immuno-modulationImmuno-suppressionImmunocompromised Patients+2 more
Fondazione IRCCS Policlinico San Matteo di Pavia 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07275580
What this trial is testing

Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Autoimmune Rheumatic DiseasesTooth ExtractionInfection Prevention+1 more
University of Sao Paulo General Hospital 352
Not applicableStudy completedNCT06738082
What this trial is testing

Influenza Vaccine Elicited Immune Response in Immunocompromised Patients

Who this might be right for
Influenza VaccineImmunocompromised Patients
Insel Gruppe AG, University Hospital Bern 147
Not applicableLooking for participantsNCT07321808
What this trial is testing

Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients

Who this might be right for
Immunocompromised Patients
Fondazione IRCCS Policlinico San Matteo di Pavia 300
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Not applicableLooking for participantsNCT06755814
What this trial is testing

ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)

Who this might be right for
Community Acquired Pneumonia (CAP)
Societa Italiana di Pneumologia 1,298
Not applicableEnded earlyNCT05655546
What this trial is testing

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Who this might be right for
ImmunodeficiencyImmunosuppressionHIV Infections+7 more
Scripps Translational Science Institute 2,117
Large-scale testing (Phase 3)Study completedNCT00162682
What this trial is testing

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

Who this might be right for
HIV Infections
Institut de Recherche pour le Developpement 716
Post-approval studies (Phase 4)Not Yet RecruitingNCT07357103
What this trial is testing

Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)

Who this might be right for
PneumocystisPneumocystis InfectionPneumocystis Carinii Infection+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 416
Not applicableStudy completedNCT05633927
What this trial is testing

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

Who this might be right for
SARS-CoV-2 RNA VaccinesHIV Infection
Hospitales Universitarios Virgen del Rocío 48
Large-scale testing (Phase 3)UnknownNCT00215007
What this trial is testing

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
MalignancyAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany
Early research (Phase 1)Study completedNCT01137669
What this trial is testing

ZOSTAVAX® in Renal Transplant Patients

Who this might be right for
Herpes Zoster
National Institute of Allergy and Infectious Diseases (NIAID) 34
Not applicableWithdrawnNCT05672654
What this trial is testing

Evaluation of Post-SARS-CoV-2 Vaccinal Response in Immunocompromised Patients

Who this might be right for
HIV SeropositivityImmunodeficiencyVaccination Reaction+1 more
University Hospital, Ghent
Not applicableUnknownNCT05905380
What this trial is testing

Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients

Who this might be right for
COVID-19 Convalescent Plasma Treatment
University Hospital, Strasbourg, France 200
Not applicableUnknownNCT02456818
What this trial is testing

Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards

Who this might be right for
Oncology [See Also, Affected System]Hematological DiseaseInfection Due to ESBL Escherichia Coli
University of Cologne 2,264
Testing effectiveness (Phase 2)UnknownNCT05736913
What this trial is testing

Intradermal COVID-19 Vaccination in the Immunocompromised

Who this might be right for
COVID-19
The University of Hong Kong 130
Testing effectiveness (Phase 2)Looking for participantsNCT07388615
What this trial is testing

The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children

Who this might be right for
Cryptosporidium Infection
Al-Azhar University 60
Very early researchWithdrawnNCT03336372
What this trial is testing

Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

Who this might be right for
Molluscum Contagiosum
Center for Clinical Studies, Texas
Not applicableLooking for participantsNCT07299500
What this trial is testing

Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital

Who this might be right for
Cerebral Toxoplasmosis
University Hospital, Strasbourg, France 30
Large-scale testing (Phase 3)WithdrawnNCT06028841
What this trial is testing

A Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV)

Who this might be right for
Chikungunya Virus Infection
Valneva Austria GmbH
Next Page